Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.077 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |